Page last updated: 2024-10-26

dipyridamole and Myotonic Dystrophy

dipyridamole has been researched along with Myotonic Dystrophy in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Myotonic Dystrophy: Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Podolski, JL1
Lubansky, HJ1
Sarpel, G1
Danon, MJ1
Lazowski, E1
Omachi, A1

Other Studies

1 other study available for dipyridamole and Myotonic Dystrophy

ArticleYear
Erythrocyte membrane lysophospholipase activity in muscular dystrophy.
    Journal of the neurological sciences, 1983, Volume: 59, Issue:3

    Topics: Dipyridamole; Enzyme Activation; Erythrocyte Membrane; Erythrocytes; Glycerylphosphorylcholine; Huma

1983